Blog Stats
- 84,171 hits
www.friedmanconsultingllc.com
Blogroll
Franck's Pharmacy
InfuPharma
IPA Canada Seminars
New England Compounding Center
TUNGSTEN SHIELD WEBINARS
Warning Letters
-
Recent Posts
- FDA CDER Most Frequent Form FDA 483 Observations Fiscal Year 2012
- APOTEX INC RECEIVES WARNING LETTER FOR MULTIPLE CANADIAN SITES (2/21/13) PART II
- APOTEX INC RECEIVES WARNING LETTER FOR MULTIPLE CANADIAN SITES (2/21/13)
- JUBILANT HOLLISTERSTIER RECEIVES WARNING LETTER (2/13/13)
- MEDI-FARE DRUG AND HOME HEALTH CENTER, BLACKSBURG, SC RECEIVES WARNING LETTER (3/7/13)
Archives
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
Categories
- 483
- Adverse Determination Letter
- Compounding Pharmacy
- Consent Decree
- Dietary Supplements
- FDA Compliance
- Import Alert
- Import Ban
- Microbiological Issues
- New Guidances for Industry
- Permanent Injunction
- Positron Emission Tomography (PET)
- Purpose and Scope
- Recall
- Regulatory Compliance
- Seizure
- Uncategorized
- Warning Letters
- Webinar
Pages
- 2013 UPCOMING WEBINAR/CONFERENCES/SEMINARS (UPDATED 02/28/13)
- ABOUT
- “HOT TOPICS” AVAILABLE FOR USP GENERAL CHAPTER PET 823
- Guidance – PET Drugs – cGMP (August 2011)
- MEDIA FILLS FOR VALIDATION OF ASEPTIC PREPARATIONS FOR POSITRON EMISSION TOMOGRAPHY(PET)
- Proposed Changes to USP General Chapter 823 March 30, 2011
- REGULATORY COMPLIANCE/EXPERT MICROBIOLOGICAL WITNESS CONSULTATION
- USP 61/62 FREQUENTLY ASKED QUESTIONS
Tags
Accugenix API Aseptic Processing Bacillus cereus bacterial contamination Ben Venue CDER CMO Consent Decree DNA Sequencing Environmental Monitoring FDA FDA 483 FDA Compliance FDA Guidance for Industry Growth Promotion H & P Industries Hospira interventions Johnson & Johnson McNeil-PPC media fills microbial contamination NECC Objectionable microorganisms Observations OOS PDI Permanent Injunction PET Puerto Rico purified water Ranbaxy Recall seizure sterile drug products Sterility Sterility Test training Triad Group USP USP 62 Validation Warning Letter Warning LettersMeta
Monthly Archives: September 2011
MEDIA FILLS FOR VALIDATION OF ASEPTIC PREPARATIONS FOR POSITRON EMISSION TOMOGRAPHY (PET) DRUGS
CDER RELEASES A NEW PET DRAFT GUIDANCE CDER has just released as a DRAFT the following Guidance for Industry, “Media Fills for Validation of Aseptic Preparation for Positron Emission Tomography (PET) Drugs. The Comment period will be 90 days. Please … Continue reading
SECOND WIPE-MAKER ISSUES RECALL AFTER BACTERIA DETECTED
NON-STERILE WIPES RECALLED ON SEPTEMBER 16, 2011 FOLLOWING DISCOVERY OF LOW LEVELS OF BACILLUS CEREUS COMMENT Bacillus cereus was recently identified within non-sterile alcohol prep wipes manufactured by Professional Disposables International Inc (PDI), Orangeburg, NY. The recall of five lots … Continue reading
MIRAMAR COSMETICS RECEIVES WARNING LETTER (AUGUST 18, 2011)
WARNING LETTER IS RECEIVED FOR REPEAT VIOLATIONS AND OBJECTIONABLE (SPECIFIED) MICROORGANISMS COMMENT Miramar Cosmetics of Doral, Florida received a Warning Letter for repeat violations from 2007, the presence of objectionable (“specified”) microorganisms, responding after 15 business days after the Form … Continue reading
610.12 CBER PROPOSED STERILITY TESTS
PART 610.12— CBER GENERAL BIOLOGICAL PRODUCTS STANDARDS PROPOSED COMMENT Enclosed is the summary of the proposed requirements for the revised CBER 610.12 Sterility Test. Comments are due by September 19, 2011. For additional information, please see below for a summary or … Continue reading
